These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20656346)

  • 1. Molecular imprinted macroporous chitosan coated mesoporous silica xerogels for hemorrhage control.
    Dai C; Liu C; Wei J; Hong H; Zhao Q
    Biomaterials; 2010 Oct; 31(30):7620-30. PubMed ID: 20656346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-Coated Diatom Silica as Hemostatic Agent for Hemorrhage Control.
    Feng C; Li J; Wu GS; Mu YZ; Kong M; Jiang CQ; Cheng XJ; Liu Y; Chen XG
    ACS Appl Mater Interfaces; 2016 Dec; 8(50):34234-34243. PubMed ID: 27998147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-pot preparation of silica-supported hybrid immobilized metal affinity adsorbent with macroporous surface based on surface imprinting coating technique combined with polysaccharide incorporated sol--gel process.
    Li F; Li XM; Zhang SS
    J Chromatogr A; 2006 Oct; 1129(2):223-30. PubMed ID: 16860332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradable, antibacterial silver exchanged mesoporous silica spheres for hemorrhage control.
    Dai C; Yuan Y; Liu C; Wei J; Hong H; Li X; Pan X
    Biomaterials; 2009 Oct; 30(29):5364-75. PubMed ID: 19625081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic enhancement of hemostatic performance of mesoporous silica by hydrocaffeic acid and chitosan.
    Chen J; Ai J; Chen S; Xu Z; Lin J; Liu H; Chen Q
    Int J Biol Macromol; 2019 Oct; 139():1203-1211. PubMed ID: 31415855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bioactive coating of a silica xerogel/chitosan hybrid on titanium by a room temperature sol-gel process.
    Jun SH; Lee EJ; Yook SW; Kim HE; Kim HW; Koh YH
    Acta Biomater; 2010 Jan; 6(1):302-7. PubMed ID: 19531388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein recognition onto silica particles using chitosan as intermedium substrate.
    Xia YQ; Guo TY; Zhao HL; Song MD; Zhang BH; Zhang BL
    J Biomed Mater Res A; 2009 Aug; 90(2):326-32. PubMed ID: 18508338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid hemostatic sponge based on large, mesoporous silica nanoparticles and N-alkylated chitosan.
    Chen Z; Han L; Liu C; Du Y; Hu X; Du G; Shan C; Yang K; Wang C; Li M; Li F; Tian F
    Nanoscale; 2018 Nov; 10(43):20234-20245. PubMed ID: 30361737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxybutyl chitosan/diatom-biosilica composite sponge for hemorrhage control.
    Zhang K; Li J; Wang Y; Mu Y; Sun X; Su C; Dong Y; Pang J; Huang L; Chen X; Feng C
    Carbohydr Polym; 2020 May; 236():116051. PubMed ID: 32172865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane of hybrid chitosan-silica xerogel for guided bone regeneration.
    Lee EJ; Shin DS; Kim HE; Kim HW; Koh YH; Jang JH
    Biomaterials; 2009 Feb; 30(5):743-50. PubMed ID: 19027950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Droplet-Fabricated Mesoporous Silica-Based Nanohybrid Granules for Hemorrhage Control.
    Zhou H; Wang C; Niu H; Duan B; Ma X; Hong H; Yuan Y; Liu C
    J Biomed Nanotechnol; 2018 Apr; 14(4):649-661. PubMed ID: 31352939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of tetracycline imprinted xerogels: comparison of experiment and computational modeling.
    Mojica ER; Autschbach J; Bright FV; Aga DS
    Anal Chim Acta; 2011 Jan; 684(1-2):63-71. PubMed ID: 21167987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The performance of a fly-larva shell-derived chitosan sponge as an absorbable surgical hemostatic agent.
    Gu R; Sun W; Zhou H; Wu Z; Meng Z; Zhu X; Tang Q; Dong J; Dou G
    Biomaterials; 2010 Feb; 31(6):1270-7. PubMed ID: 19880175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency and Cytotoxicity of a Novel Gallium-Containing Mesoporous Bioactive Glass/Chitosan Composite Scaffold as Hemostatic Agents.
    Pourshahrestani S; Zeimaran E; Kadri NA; Gargiulo N; Jindal HM; Naveen SV; Sekaran SD; Kamarul T; Towler MR
    ACS Appl Mater Interfaces; 2017 Sep; 9(37):31381-31392. PubMed ID: 28836753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant batroxobin-coated nonwoven chitosan as hemostatic dressing for initial hemorrhage control.
    Seon GM; Lee MH; Kwon BJ; Kim MS; Koo MA; Seomun Y; Kim JT; Kim TH; Park JC
    Int J Biol Macromol; 2018 Jul; 113():757-763. PubMed ID: 29514041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties.
    Ong SY; Wu J; Moochhala SM; Tan MH; Lu J
    Biomaterials; 2008 Nov; 29(32):4323-32. PubMed ID: 18708251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica nanoparticles carried on chitosan microspheres for traumatic bleeding control.
    Sun X; Fang Y; Tang Z; Wang Z; Liu X; Liu H
    Int J Biol Macromol; 2019 Apr; 127():311-319. PubMed ID: 30639594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel highly porous silica and chitosan-based hemostatic dressing is superior to HemCon and gauze sponges.
    Englehart MS; Cho SD; Tieu BH; Morris MS; Underwood SJ; Karahan A; Muller PJ; Differding JA; Farrell DH; Schreiber MA
    J Trauma; 2008 Oct; 65(4):884-90; discussion 890-2. PubMed ID: 18849807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharides-modified chitosan as improved and rapid hemostasis foam sponges.
    Wei X; Ding S; Liu S; Yang K; Cai J; Li F; Wang C; Lin S; Tian F
    Carbohydr Polym; 2021 Jul; 264():118028. PubMed ID: 33910719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and hemostatic evaluation of chitosan composite hemostatic membrane].
    Li B; Huang Y; Zhang Y; Sun Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Mar; 24(3):340-3. PubMed ID: 20369538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.